story of the week
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
N. Engl. J. Med 2020 Oct 22;383(17)1613-1623, R Foà, R Bassan, A Vitale, L Elia, A Piciocchi, MC Puzzolo, M Canichella, P Viero, F Ferrara, M Lunghi, F Fabbiano, M Bonifacio, N Fracchiolla, P Di Bartolomeo, A Mancino, MS De Propris, M Vignetti, A Guarini, A Rambaldi, S ChiarettiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.